This year’s conference was fantastic and productive for our company on numerous levels. First of all, our new Backlit Trade Show Booth attracted strong, consistent traffic from interested prospects, partners, and collaborators. Our cool TRANBERG Laser Demo was also a hit showing off our precisely controlled Focal Laser Ablation technology.
Throughout the conference, numerous urologists and potential business partners from the US and EU showed strong interest in our TRANBERG Thermal Therapy system and its minimally invasive approach to treating prostate tissue. We’re currently following up with everyone. Stay tuned for more exciting outcomes!
On behalf of the CLS AUA23 team, thank you to everyone for stopping by. It was my pleasure to meet many of you. I look forward to hopefully hearing from you again in the future should our clinical or business interests align. Best of luck in 2023!
Sincerely,
Michael Magnani, President CLS Americas
The CLS team at the AUA2023. Right to Left: Lotta Nilsson,VP Marketing, CLS AB; Rick Wilderotter, Director, Business Development, CLS America’s Inc.; Michael Magnani, President, CLS America’s Inc., and Amani Abou-Zamzam MBA, Urology Strategy Consultant. Joel Hix, Director, Clinical Operations, CLS America’s Inc. (not pictured).
CLS also hosted a private KOL dinner reception where Dr. Fernando Bianco was able to share some early results from our first office-based focal laser ablation cases in America. The first twenty patients have been safely treated and follow up is now ongoing.
Read more about the study here.
Want to learn more about our 510(k) cleared TRANBERG™ products and latest news?
Fill out the form below and we´ll contact you.
Phone:+1 (949) 504-5440
Phone: +1 (480)363-8774
Our latest news are displayed below (links to CLS America webpage).
Last week we joined the 2024 Congress of Neurological Surgeons (CNS) meeting in Houston where our partner ClearPoint Neuro, Inc. exhibited the ClearPoint Prism® Neuro Laser Therapy System, powered by CLS. In addition to good booth traffic and customer discussions, we also took part in the scientific program providing the latest updates on the use of Laser Interstitial Thermal Therapy (LITT) in neurosurgery.
For the first time results from the CLS-sponsored study at Skåne University Hospital (SUS) will be presented and discussed during an international scientific congress. We are happy to share the abstract OP033 “Laser interstitial thermal therapy using an uncooled laser catheter in a diagnostic MR suite” by Dr Hjalmar Bjartmarz et al.
Since CLS´s laser ablation system for neurosurgery was cleared by the FDA in September last year development has progressed rapidly. But how does it actually work? We explain in this news post.
Welcome to Clinical Laserthermia Systems.
Please note that all our products and indications are not yet approved in all markets. Don’t hesitate to contact us for up-to-date market approvals in your area!
Please choose your country or region
Clinical Laserthermia Systems Americas Inc.
3 Park Plaza, Suite 1700
Irvine, CA 92614 USA
Phone: +1 (949) 504-5440
E-mail: contact-us@clinicallaser.com
©Copyright 2024 CLS AB. All rights reserved.
MM-2022-026-US/Rev3